Medical device body fluid immersion testing evaluates the chemical stability, degradation behavior, and biological safety of device materials after exposure to simulated physiological fluids such as blood plasma, saliva, synovial fluid, and gastric juice. Performed in line with the ISO 10993 series, ASTM corrosion standards, and GB/T 16886 requirements, this testing delivers essential evidence for biocompatibility assessment and regulatory submission. This article explains the test principles, sample categories, evaluation items, laboratory methods, and typical applications of body fluid immersion testing for medical devices.
Technical Overview
Body fluid immersion testing is a laboratory procedure in which a medical device, component, or material coupon is fully immersed in a simulated physiological fluid under controlled temperature, pH, and duration in order to characterize how the device will behave during clinical contact with body tissues and fluids. During actual use, devices are exposed to blood, interstitial fluid, synovial fluid, saliva, gastric fluid, intestinal fluid, urine, or cerebrospinal fluid. Each of these environments can trigger hydrolysis, oxidation, swelling, leaching of additives, metal ion release, corrosion, or surface deposit formation, all of which may compromise device performance or patient safety.
The test supports the biological evaluation framework of ISO 10993-1 (GB/T 16886.1), the sample preparation rules of ISO 10993-12, the degradation assessment requirements of ISO 10993-13 (polymeric devices), ISO 10993-14 (ceramics), and ISO 10993-15 (metals and alloys), and the chemical characterization approach of ISO 10993-18. For metallic implants, ASTM G31 provides gravimetric immersion corrosion methodology, ASTM F2129 and ASTM F746 address electrochemical corrosion behavior in simulated physiological solutions, and ISO 23317 defines simulated body fluid (SBF) for evaluating the apatite-forming ability of bioactive surfaces.
Common Simulated Physiological Fluids
- Phosphate-buffered saline (PBS) at pH 7.4 for general screening and extract generation
- Simulated body fluid (SBF) with ion concentrations approximating human blood plasma, pH 7.40 at 36.5 °C, per ISO 23317
- Artificial saliva, with or without mucin, for dental and oral-contacting devices
- Artificial perspiration for percutaneous components and skin-contacting metal parts
- Artificial gastric fluid (acidic, pepsin-containing) and artificial intestinal fluid (neutral, pancreatin-containing) for ingestible devices
- Artificial urine for catheters, stents, and other urological devices
- Diluted calf serum or hyaluronic acid solution as a synovial fluid simulant for orthopedic devices
- Anticoagulated blood or blood substitutes for hemocompatibility screening consistent with ASTM F756
Testing Samples
Metallic Implants and Trauma Devices
Titanium alloys, cobalt-chromium alloys, and stainless steels used in bone plates, screws, intramedullary nails, spinal fixation systems, and joint replacement components are immersed to quantify ion release of elements such as Ti, Al, V, Co, Cr, Ni, and Mo, and to observe pitting, crevice corrosion, or surface passivation changes in accordance with ISO 10993-15.
Polymeric and Bioresorbable Devices
Devices made from PLA, PLGA, PEEK, polyurethane, silicone, and PVC, including absorbable scaffolds, films, and molded components, are evaluated for hydrolytic degradation, mass loss, molecular weight decline, swelling, and mechanical property retention as specified in ISO 10993-13.
Dental Materials
Resin composites, glass ionomer cements, denture base acrylics, and dental implants are tested after artificial saliva immersion for water sorption, solubility, color stability, and dimensional change, supporting requirements of the ISO 4049 family for polymer-based restorative materials.
Ophthalmic and Contact Lens Materials
Hydrogel and silicone hydrogel contact lenses, intraocular lenses, and ocular implants are immersed in saline or simulated tear fluid to assess water content stability, deposition behavior, and optical quality consistent with the ISO 18369 series.
Catheters, Tubing, and Delivery Systems
Central venous catheters, urinary catheters, infusion tubing, and drug delivery components are exposed to saline, blood substitutes, or artificial urine to evaluate plasticizer and additive leaching, softening, and burst or flow performance after fluid contact.
Wound Dressings, Hydrogels, and Topical Products
Absorbent dressings and hydrogels are tested for fluid handling capacity, gel cohesion, and structural integrity in protein- and electrolyte-containing wound exudate simulants, supporting test methods of the EN 13726 series for primary wound dressings.
Drug-Device Combination Products
Drug-eluting stents, coated balloons, and antimicrobial-coated devices are immersed in clinically relevant media to characterize drug release kinetics, coating durability, and the leachables profile of excipients and carrier polymers.
Testing Items
Physical and Mechanical Evaluation
- Visual and stereomicroscopic inspection for discoloration, cracking, delamination, swelling, and deposits
- Mass change, water absorption, swelling ratio, and solubility after drying to constant weight
- Dimensional stability including length, diameter, wall thickness, and volume expansion
- Mechanical property retention: tensile strength, elongation at break, flexural modulus, hardness, compression strength, suture retention, and burst pressure
Surface and Morphological Analysis
- Scanning electron microscopy with energy-dispersive spectroscopy (SEM/EDS) for surface morphology and elemental mapping
- Surface roughness by profilometry or atomic force microscopy
- Contact angle measurement for wettability changes
- Coating integrity and adhesion assessment after immersion
Chemical Characterization of Immersion Media
- pH, osmolality, conductivity, total organic carbon (TOC), and UV-visible absorbance of the immersion solution
- Metal ion release quantification by ICP-OES or ICP-MS
- Organic extractables and leachables by GC-MS, LC-MS, and HPLC
- Polymer molecular weight distribution by gel permeation chromatography (GPC/SEC) and thermal analysis by DSC and TGA
Corrosion, Degradation, and Biological Screening
- Gravimetric corrosion rate and localized attack assessment per ASTM G31
- Electrochemical pitting and breakdown potential testing per ASTM F2129 and ASTM F746
- Cytotoxicity screening of immersion extracts per ISO 10993-5
- Apatite-forming ability of bioactive surfaces in SBF per ISO 23317
- Toxicological risk assessment of measured degradation products per ISO 10993-17
Testing Methods
Simulated Fluid Preparation
Simulated fluids are prepared from reagent-grade salts dissolved under controlled order and temperature, buffered to physiological pH, verified by pH and osmolality measurement, and sterilized by 0.22 micrometer filtration before use. SBF is prepared and handled per ISO 23317, with pH maintained at 7.40 ± 0.05 and temperature at 36.5 °C to ensure comparability of apatite formation results.
Sample Preparation and Extraction Ratios
Test specimens are preferably taken from finished, sterilized devices, since manufacturing and sterilization processes can alter leachables and degradation behavior. When immersion media will be used for biological assays, the standardized surface-area-to-volume ratio of 3 cm² per mL (or approximately 0.2 g of material per mL for irregular samples) specified in ISO 10993-12 is applied. Stability studies may use device-to-fluid ratios that simulate clinical exposure conditions, with justification documented in the test plan.
Immersion Conditions and Duration
Immersion is typically performed at 37 °C ± 1 °C in chemically inert containers such as borosilicate glass with PTFE-lined closures, protected from light and sealed to prevent evaporation. Duration is tiered according to study objective: 24 ± 2 hours and 72 hours for extract generation, and 1, 2, 4, 8, or 12 weeks and beyond for real-time degradation studies reflecting the maximum clinical exposure duration. Accelerated conditions such as 50 °C or 70 °C may be used when justified by Arrhenius modeling. Blank fluid controls and reference material controls are included, and all fluid sampling or replacement schedules are documented.
Post-Immersion Evaluation and Reporting
Following immersion, specimens undergo defined rinsing and drying protocols, gravimetric measurement, mechanical testing, and surface analysis within specified time windows to minimize artifacts. Results are statistically compared against time-zero controls, and mass balance is established by correlating specimen mass loss with quantified leachables in the immersion media. The test report documents fluid formulation and verification data, surface-area-to-volume ratios, immersion conditions and duration, analytical methods, control results, deviations, and a conclusion against the pre-defined acceptance criteria.
Applications
- Regulatory submissions to national medical device authorities, including technical documentation for product registration and conformity assessment in major markets
- Material selection, design verification, and design validation during research and development
- Chemical characterization and toxicological risk assessment of degradation products and leachables per ISO 10993-18 and ISO 10993-17
- Extract generation for cytotoxicity, sensitization, and irritation testing within ISO 10993 biological evaluation programs
- Corrosion and ion release qualification for metallic implants in orthopedic, cardiovascular, and dental applications
- Degradation profiling of bioresorbable scaffolds, films, and drug-device combination products
- Change control when materials, suppliers, manufacturing sites, or sterilization methods are modified
- Shelf-life and aging studies supported by accelerated immersion protocols in accredited third-party laboratories
FAQ
Which simulated body fluid should be selected for my device?
Fluid selection follows the intended clinical contact site and exposure duration defined in the risk management file. Blood-contacting devices are typically tested in PBS or blood substitutes, dental devices in artificial saliva, orthopedic implants in SBF or synovial fluid simulant, urological devices in artificial urine, and ingestible devices in artificial gastric and intestinal fluids. The rationale must be documented under the evaluation framework of ISO 10993-1.
How long should the immersion last?
Extracts intended for biological assays such as cytotoxicity are commonly generated at 37 °C for 24 ± 2 hours in accordance with ISO 10993-12. Degradation and stability studies should mirror the maximum clinical exposure, which may range from several weeks for transient devices to multi-month real-time protocols for permanent implants, with accelerated conditions permitted when scientifically justified.
What are the typical acceptance criteria?
There is no universal pass or fail threshold. Acceptance criteria are device-specific and defined in advance based on intended use, clinical exposure duration, and toxicological thresholds. Common benchmarks include a defined minimum percentage of mechanical property retention, controlled mass change limits, ion and leachable concentrations below tolerable intake values derived per ISO 10993-17, and cell viability of at least 70 percent in cytotoxicity screening per ISO 10993-5.
How does immersion testing differ from extraction testing?
Extraction testing prepares fluid media for biological assays such as cytotoxicity or sensitization, whereas immersion testing is a materials performance study in which the specimen itself is examined for degradation, corrosion, mass change, and surface alteration. The two approaches are complementary components of an integrated chemical characterization and biocompatibility program.
Should testing be performed on sterilized final products?
Yes. Testing specimens in their final processed, coated, and sterilized form is strongly preferred, because sterilization methods such as gamma irradiation and ethylene oxide can generate degradation products and alter leachable profiles. Aged samples at the end of shelf life may also be included to cover the full product life cycle.
Is body fluid immersion testing destructive?
In most cases, yes. Gravimetric, mechanical, and surface analyses require specimen sacrifice, so sample quantities should be planned with adequate statistical power, including time-zero controls, blank fluid controls, and replicate groups for each immersion interval.